EMG
PACB icon

ETF Managers Group’s Pacific Biosciences PACB Stock Holding History

ETF Managers Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$545K Buy
+47,036
New +$468K 0.02% 431
2021
Q2 		– Sell
-38,656
Closed -$1.16M – 766
2021
Q1 		$1.16M Buy
+38,656
New +$1.35M 0.02% 258

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ETF Managers Group's PACB Position: Q1 2023 in Review

ETF Managers Group opened a new position in Pacific Biosciences (PACB) in Q1 2023: 47,036 shares worth $545K. The stake represents 0.02% of the portfolio and ranks #431 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in PACB as recently as Q1 2021.

ETF Managers Group first reported a position in PACB in Q1 2021 and has held it in 2 quarters since. The position peaked at $1.16M in Q1 2021. 259 funds tracked by Wall St. Rank hold PACB as of Q1 2023.

  • ETF Managers Group held 47,036 shares of Pacific Biosciences worth $545K as of Q1 2023.
  • Pacific Biosciences was a new ETF Managers Group position in Q1 2023.
  • Pacific Biosciences made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #431 holding.
  • ETF Managers Group first reported a position in Pacific Biosciences in Q1 2021 and has held it in 2 quarters since.
  • ETF Managers Group's Pacific Biosciences position peaked at $1.16M in Q1 2021.
  • 259 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.